Metabolic Insights

CRP & Liver Fat — What Employer Wellness Programs Track | 2026 Corporate wellness programs have come a long way from the biometric screening table in the break room — the one where a nurse took your blood pressure, handed you a printout, and advised you to eat more vegetables. That version still exists in a lot of organizations. But alongside it, something considerably more analytically sophisticated has been growing quietly, driven by employer healthcare cost data, advances in population health technology, and a gradually accumulating research literature that connects specific metabolic and inflammatory markers to the kind of long-horizon healthcare costs that self-insured employers and large health plan sponsors care most deeply about. CRP. Liver fat. Insulin resistance proxies. Metabolic syndrome component clustering. These aren't terms that used to appear in workforce wellness conversations. They're appearing now — not always in language that employees see direc...

Inflammation & Health Insurance Risk — What Insurers See | 2026 Most people think about health insurance risk in fairly concrete terms — a diagnosis, a prescription, a procedure that shows up in a medical record. Something documented, labeled, and handed to an underwriter. But there's a quieter category of risk that insurers and actuaries have been paying increasing attention to over the past two decades, one that lives in the gray zone between "officially sick" and "perfectly fine." Chronic low-grade inflammation sits squarely in that gray zone. It doesn't usually produce a diagnosis on its own. It doesn't have a billing code the way a fractured wrist or a documented thyroid condition does. But it shows up in blood markers. It accumulates over years. And the research connecting it to cardiovascular disease, type 2 diabetes, metabolic syndrome, and a range of costly chronic conditions has become extensive enough that the insurance industry — ...